These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 359762)

  • 1. Effect of n-dipropylacetate on amino acid concentrations in mouse brain: correlations with anti-convulsant activity.
    Schechter PJ; Tranier Y; Grove J
    J Neurochem; 1978 Nov; 31(5):1325-7. PubMed ID: 359762
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic valproic acid therapy and synaptic markers of amino acid neurotransmission.
    Slevin JT; Ferrara LP
    Neurology; 1985 May; 35(5):728-31. PubMed ID: 3921873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central actions of valproic acid in man and in experimental models of epilepsy.
    Hammond EJ; Wilder BJ; Bruni J
    Life Sci; 1981 Dec; 29(25):2561-74. PubMed ID: 6275228
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.
    Emson PC
    J Neurochem; 1976 Dec; 27(6):1489-94. PubMed ID: 794443
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content.
    Chapman AG; Meldrum BS; Mendes E
    Life Sci; 1983 Apr; 32(17):2023-31. PubMed ID: 6403794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of anticonvulsant action of valproate.
    Chapman A; Keane PE; Meldrum BS; Simiand J; Vernieres JC
    Prog Neurobiol; 1982; 19(4):315-59. PubMed ID: 6134304
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system.
    Cotariu D; Zaidman JL; Evans S
    Prog Neurobiol; 1990; 34(4):343-54. PubMed ID: 2110371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of sodium n-dipropylacetate on the GABA level in various areas of the mouse brain].
    Simler S; Gensburger C; Ciesielski L; Mandel P
    C R Seances Soc Biol Fil; 1976; 170(6):1285-8. PubMed ID: 140750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution in brain and effect on cerebral mitochondrial respiration of the anticonvulsive drug n-dipropylacetate.
    Ciesielski L; Maitre M; Cash C; Mandel P
    Biochem Pharmacol; 1975 May; 24(9):1055-8. PubMed ID: 1098668
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticonvulsant activity and effects of sodium dipropylacetate on cerebral 5-hydroxytryptamine and gamma-aminobutyric acid in reserpinized mice.
    Kukino K; Deguchi T
    Chem Pharm Bull (Tokyo); 1978 Nov; 26(11):3551-5. PubMed ID: 365378
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of anticonvulsant drugs on brain amino acid metabolism.
    Chapman AG; Meldrum BS
    Prog Clin Biol Res; 1983; 124():63-76. PubMed ID: 6410409
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection by GABA agonists, gamma-hydroxybutyric acid, and valproic acid against seizures evoked in epileptic chicks by hyperthermia.
    Pedder SC; Wilcox R; Tuchek J; Johnson DD; Crawford RD
    Epilepsia; 1988; 29(6):738-42. PubMed ID: 3142760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sodium dipropylacetate on experimental spike foci.
    Goldensohn ES; Bustamante LA; Lueders H; Pippenger C
    Trans Am Neurol Assoc; 1977; 102():167-9. PubMed ID: 356395
    [No Abstract]   [Full Text] [Related]  

  • 14. Time course of the increase in GABA level in different mice brain regions following N-dipropylacetate treatment.
    Simler S; Gensburger C; Ciesielski L; Mandel P
    Commun Psychopharmacol; 1978; 2(2):123-30. PubMed ID: 352606
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of central GABA-ergic systems in convulsions and aggressive behavior.
    Mandel P; Ciesielski L; Maitre M; Simler S; Mack G; Kempf E
    Adv Exp Med Biol; 1979; 123():475-92. PubMed ID: 390995
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcitonin potentiates the anticonvulsant and antinociceptive effects of valproic acid and pregabalin in pentylenetetrazole-kindled mice.
    Hamada NM; Ashour RH; Shalaby AA; El-Beltagi HM
    Eur J Pharmacol; 2018 Jan; 818():351-355. PubMed ID: 29104044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of drugs on rat brain, cerebrospinal fluid and blood GABA content.
    Ferkany JW; Butler IJ; Enna SJ
    J Neurochem; 1979 Jul; 33(1):29-33. PubMed ID: 379280
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
    Nau H; Löscher W
    J Pharmacol Exp Ther; 1982 Mar; 220(3):654-9. PubMed ID: 6801254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of n-dipropylacetate and amino-oxyacetic acid on gamma-aminobutyric acid levels in discrete areas of rat brain.
    Iadarola MJ; Raines A; Gale K
    J Neurochem; 1979 Nov; 33(5):1119-23. PubMed ID: 387917
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.